Company: RNAC
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0001453687-25-000075
Chunk: 79

Company: Cartesian Therapeutics, Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 79
---
 of the Committee other than the chairman.

Following review of a competitive assessment performed by Compensia, effective December 12, 2024, the Board approved the following amendments to our non-employee director compensation program, which are intended to align our program with the median of market:

• Increasing the annual equity awards from options to purchase 4,000 shares of Common Stock to options to purchase 8,000 shares of Common Stock for the Chairman of the Board and from options to purchase 3,800 shares of Common Stock to options to purchase 7,800 shares of Common Stock for each other non-employee director, and increasing the initial grant from options to purchase 8,266 shares of Common Stock to options to purchase 17,866 shares of Common Stock for the Chairman of the Board and from options to purchase 7,600 shares of Common Stock to options to purchase 17,200 shares of Common Stock for each other non-employee director and reducing the initial grant from 5,933 RSUs to 5,800 RSUs;

• Increasing the annual retainer for the Chairman of the Board from $30,000 to $35,000;

• Increasing the additional annual retainer from $15,000 to $20,000 for the chairman of the Audit Committee and from $7,500 to $10,000 for any Audit Committee member other than the chairman;

<div align='center'>46</div>

• Increasing the additional annual retainer from $12,000 to $15,000 for the chairman of the Compensation Committee and from $6,000 to $7,500 for any Compensation Committee member other than the chairman; and

• Increasing the additional annual retainer from $12,000 to $15,000 for the chairman of the Science and Technology Committee and from $6,000 to $7,500 for any Science and Technology Committee member other than the chairman.

Dr. Brunn, our President and Chief Executive Officer, also serves on our Board but receives no additional compensation for this service.

The following table sets forth the compensation earned to our non-employee directors for their service on our Board during 2024.

#### 2024 Director Compensation Table
| Name                          |     | Fees earned or paid in cash ($)(1) |        |     | Stock awards ($)(2) |         |     | Option awards ($)(2) |         |     | All other compensation ($) |   |     | Total ($) |         |
| Timothy C. Barabe, M.B.A